Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
US6849661B2 · kind B2 · utility
2Cited by
7References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2002 |
| Grant date | Feb 1, 2005 |
| Priority date | — |
| Expiry date | Jan 12, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods of treating, preventing, and/or managing abnormal increases in gastrointestinal motility, and intestinal conditions that cause the same. Such conditions include, but are not limited to, irritable bowel syndrome (IBS), infectious diseases of the small and large intestines, and symptoms of any of the foregoing. In particular, the present invention discloses methods of using enriched (R)-verapamil, as well as compositions and formulations containing the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.